Liver cancer stem cells as an important target in liver cancer therapies

Anti-Cancer Agents in Medicinal Chemistry

Volumn 10, Issue 2, 2010, Pages 172-175

  Zou, Gang Ming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

CD133; CD44; CD90; IL 6; TGF

Indexed keywords

ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ALPHA FETOPROTEIN; BETA CATENIN; BIOLOGICAL MARKER; BMI1 PROTEIN; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CHROMOGRANIN A; DOXORUBICIN; EPHEDRINE; FLUOROURACIL; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; HERMES ANTIGEN; INTERLEUKIN 6; METHIONINE ADENOSYLTRANSFERASE; MULTIDRUG RESISTANCE PROTEIN 1; NERVE CELL ADHESION MOLECULE; STEM CELL FACTOR; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

CANCER CELL CULTURE; CANCER CONTROL; CANCER RESISTANCE; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CELL POPULATION; CELL RENEWAL; CELL TRANSFORMATION; CHEMOSENSITIVITY; ENZYME SYNTHESIS; GENE INSERTION; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LIVER CANCER; METASTASIS; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; TARGET CELL;

EID: 77950797970     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152010790909263     Document Type: Review

References (27)

1. Bruix, J.; Llovet, J. M. Major achievements in hepatocellular carcinoma. Lancet, 2009, 373 (9664), 614-616.
2. Poon, D.; Anderson, B. O.; Chen, L. T.; Tanaka, K.; Lau, W. Y.; Van Cutsem, E.; Singh, H.; Chow, W. C.; Ooi, L. L.; Chow, P.; Khin, M. W.; Koo, W. H. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol., 2009, 10 (11), 1111-1118.
3. Suetsugu, A.; Nagaki, M.; Aoki, H.; Motohashi, T.; Kunisada, T.; Moriwaki, H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem. Biophys. Res. Commun., 2006, 351 (4), 820-824.
4. Ma, S.; Chan, K. W.; Hu, L.; Lee, T. K.; Wo, J. Y.; Ng, I. O.; Zheng, B. J.; Guan, X. Y. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology, 2007, 132 (7), 2542-2556.
5. Chiba, T.; Zheng, Y. W.; Kita, K.; Yokosuka, O.; Saisho, H.; Onodera, M.; Miyoshi, H.; Nakano, M.; Zen, Y.; Nakanuma, Y.; Nakauchi, H.; Iwama, A.; Taniguchi, H. Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology, 2007, 133 (3), 937-950.
6. Yin, S.; Li, J.; Hu, C.; Chen, X.; Yao, M.; Yan, M.; Jiang, G.; Ge, C.; Xie, H.; Wan, D.; Yang, S.; Zheng, S.; Gu, J. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer, 2007, 120 (7), 1444-1450.
7. Zhu, Z.; Hao, X.; Yan, M.; Yao, M.; Ge, C.; Gu, J.; Li, J. Cancer stem/progenitor cells are highly enriched in CD133(+)CD44(+) population in hepatocellular carcinoma. Int. J. Cancer, 2009, [Epub ahead of Print].
8. Suzuki, A.; Zheng, Y.; Kondo, R.; Kusakabe, M.; Takada, Y.; Fukao, K.; Nakauchi, H.; Taniguchi, H. Flow-cytometric separation and enrichment of hepatic progenitor cells in the developing mouse liver. Hepatology, 2000, 32 (6), 1230-1239.
9. Allain, J. E.; Dagher, I.; Mahieu-Caputo, D.; Loux, N.; Andreoletti, M.; Westerman, K.; Briand, P.; Franco, D.; Leboulch, P.; Weber, A. Immortalization of a primate bipotent epithelial liver stem cell. Proc. Natl. Acad. Sci. USA, 2002, 99 (6), 3639-3644.
10. Schmelzer, E.; Zhang, L.; Bruce, A.; Wauthier, E.; Ludlow, J.; Yao, H. L.; Moss, N.; Melhem, A.; McClelland, R.; Turner, W.; Kulik, M.; Sherwood, S.; Tallheden, T.; Cheng, N.; Furth, M. E.; Reid, L. M. Human hepatic stem cells from fetal and postnatal donors. J. Exp. Med., 2007, 204 (8), 1973-1987.
11. Marrero, J. A. Hepatocellular carcinoma. Curr. Opin. Gastroenterol., 2005, 21 (3), 308-312.
12. Alison, M. R.; Golding, M.; Sarraf, C. E.; Edwards, R. J.; Lalani, E. N. Liver damage in the rat induces hepatocyte stem cells from biliary epithelial cells. Gastroenterology, 1996, 110 (4), 1182-1190.
13. Yasui, O.; Miura, N.; Terada, K.; Kawarada, Y.; Koyama, K.; Sugiyama, T. Isolation of oval cells from long-evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver. Hepatology, 1997, 25 (2), 329-334.
14. Zou, G. M. Cancer stem cells in leukemia, recent advances. J. Cell Physiol., 2007, 213 (2), 440-444.
15. Dovey, J. S.; Zacharek, S. J.; Kim, C. F.; Lees, J. A. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc. Natl. Acad. Sci. USA, 2008, 105 (33), 11857-11862.
16. Moon, J. H.; Yoon, B. S.; Kim, B.; Park, G.; Jung, H. Y.; Maeng, I.; Jun, E. K.; Yoo, S. J.; Kim, A.; Oh, S.; Whang, K. Y.; Kim, H.; Kim, D. W.; Kim, K. D.; You, S. Induction of neural stem cell-like cells (NSCLCs) from mouse astrocytes by Bmi1. Biochem. Biophys. Res. Commun., 2008, 371 (2), 267-272.
17. Gattinoni, L.; Zhong, X. S.; Palmer, D. C.; Ji, Y.; Hinrichs, C. S.; Yu, Z.; Wrzesinski, C.; Boni, A.; Cassard, L.; Garvin, L. M.; Paulos, C. M.; Muranski, P.; Restifo, N. P. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat. Med., 2009, 15 (7), 808-813.
18. Evans, T. Fishing for a WNT-PGE2 link: beta-catenin is caught in the stem cell net-work. Cell Stem Cell, 2009, 4 (4), 280-282.
19. Yang, Z. F.; Ho, D. W.; Ng, M. N.; Lau, C. K.; Yu, W. C.; Ngai, P.; Chu, P. W.; Lam, C. T.; Poon, R. T.; Fan, S. T. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell, 2008, 13 (2), 153-166.
20. Ma, S.; Chan, K. W.; Lee, T. K.; Tang, K. H.; Wo, J. Y.; Zheng, B. J.; Guan, X. Y. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol. Cancer Res., 2008, 6 (7), 1146-1153.
21. Ma, S.; Lee, T. K.; Zheng, B. J.; Chan, K. W.; Guan, X. Y. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene, 2008, 27 (12), 1749-1758.
22. Yang, Z. F.; Ngai, P.; Ho, D. W.; Yu, W. C.; Ng, M. N.; Lau, C. K.; Li, M. L.; Tam, K. H.; Lam, C. T.; Poon, R. T.; Fan, S. T. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology, 2008, 47 (3), 919-928. (Pubitemid 351449683)
23. Amin, R.; Mishra, L. Liver stem cells and tgf-Beta in hepatic carcinogenesis. Gastrointest Cancer Res., 2008, 2 (4 Suppl), S27-S30.
24. Tang, Y.; Kitisin, K.; Jogunoori, W.; Li, C.; Deng, C. X.; Mueller, S. C.; Ressom, H. W.; Rashid, A.; He, A. R.; Mendelson, J. S.; Jessup, J. M.; Shetty, K.; Zasloff, M.; Mishra, B.; Reddy, E. P.; Johnson, L.; Mishra, L. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc. Natl. Acad. Sci. USA, 2008, 105 (7), 2445-2450.
25. Rountree, C. B.; Senadheera, S.; Mato, J. M.; Crooks, G. M.; Lu, S. C. Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology, 2008, 47 (4), 1288-1297.
26. Ding, W.; Mouzaki, M.; You, H.; Laird, J. C.; Mato, J.; Lu, S. C.; Rountree, C. B. CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology, 2009, 49(4), 1277-1286.
27. Lau, C. K.; Yang, Z. F.; Ho, D. W.; Ng, M. N.; Yeoh, G. C. T.; Poon, R. T. P.; Fan, S. T. An Akt/hypoxia-inducible factor-1{alpha}/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Clin. Cancer Res., 2009, 15 (10), 3462-3471.